Shares of Extendicare Inc. (TSE:EXE – Get Free Report) reached a new 52-week high during mid-day trading on Wednesday . The company traded as high as C$20.17 and last traded at C$20.09, with a volume of 329320 shares trading hands. The stock had previously closed at C$19.76.
Analysts Set New Price Targets
Several brokerages have recently commented on EXE. BMO Capital Markets increased their price objective on Extendicare from C$15.00 to C$21.00 in a research note on Monday. National Bankshares upped their price target on Extendicare from C$16.10 to C$17.50 and gave the stock an “outperform” rating in a report on Wednesday, October 8th. Cibc World Mkts upgraded Extendicare to a “strong-buy” rating in a research note on Monday, September 22nd. CIBC lifted their price objective on shares of Extendicare from C$18.00 to C$22.00 in a report on Thursday, November 13th. Finally, TD Securities increased their target price on shares of Extendicare from C$15.00 to C$19.00 in a report on Thursday, November 13th. Two analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of C$18.10.
Extendicare Stock Up 1.7%
Extendicare Announces Dividend
The firm also recently announced a monthly dividend, which was paid on Monday, November 17th. Stockholders of record on Monday, November 17th were paid a dividend of $0.042 per share. This represents a c) dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date was Friday, October 31st. Extendicare’s payout ratio is presently 46.60%.
Extendicare Company Profile
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Recommended Stories
- Five stocks we like better than Extendicare
- 3 Stocks to Consider Buying in October
- What’s on the Thanksgiving Table? A Stock Pick for Every Course
- Which Wall Street Analysts are the Most Accurate?
- Why Home Depot’s Pain Could Be a Long-Term Investor’s Gain
- How to trade penny stocks: A step-by-step guide
- Qualcomm’s Bulls Are Running Out of Room to Be Wrong
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
